Difference between revisions of "Template:Correction FADH2 and S-pathway"
From Bioblast
(Created page with "== Correction: FADH<sub>2</sub> and S-pathway == :::» Complex II ambiguities :::: A commonly found error on FADH<sub>2</sub> in the S-pathway requires correction. For cl...") |
|||
| Line 1: | Line 1: | ||
== Correction: FADH<sub>2</sub> and S-pathway == | == Correction: FADH<sub>2</sub> and S-pathway == | ||
:::» [[Complex II ambiguities]] | :::» '''[[Complex II ambiguities]]''' | ||
:::: A commonly found error on FADH<sub>2</sub> in the S-pathway requires correction. For clarification, see page 48 in [[Gnaiger_2020_BEC_MitoPathways |Gnaiger (2020)]] | :::: A commonly found error on FADH<sub>2</sub> in the S-pathway requires correction. For clarification, see page 48 in [[Gnaiger_2020_BEC_MitoPathways |Gnaiger (2020)]] | ||
Revision as of 13:15, 19 March 2023
Correction: FADH2 and S-pathway
- A commonly found error on FADH2 in the S-pathway requires correction. For clarification, see page 48 in Gnaiger (2020)
- Quote (p 48): "The substrate of CII is succinate, which is oxidized forming fumarate while reducing flavin adenine dinucleotide FAD to FADH2, with further electron transfer to the quinone pool. Whereas reduced NADH is a substrate of Complex I linked to dehydrogenases of the TCA cycle and mt-matrix upstream of CI, reduced FADH2 is a product of Complex II with downstream electron flow from CII to Q."
- A commonly found error on FADH2 in the S-pathway requires correction. For clarification, see page 48 in Gnaiger (2020)
- Gnaiger E (2020) Mitochondrial pathways and respiratory control. An introduction to OXPHOS analysis. 5th ed. Bioenerg Commun 2020.2. https://doi.org/10.26124/bec:2020-0002
